<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250112064358N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-08-28</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effects of Dry Needling and Kinesio Taping on Pain and Brain Function in People with Neck Muscle Pain</public_title>
      <acronym></acronym>
      <scientific_title>The Effects of Combination of Dry Needling and Kinesio Taping on Clinical Symptoms and Neurocognitive Parameters in Patients with Upper Trapezius Trigger Points</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>54</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/82301</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients will be divided at random into three groups: only DN, only KT, and combination of DN and KT . Using sealed, randomly filled envelopes with information on the intervention groups, randomization will be carried out. Three envelopes are made, and one of the three approaches is written in each one. The first person to arrive is asked to select an envelope. The third person now owns the third envelope since we also want the second person to select an envelope. For the following three people, the same cycle is repeated, Blinding description: For this study, both  the assessors  and analyzer of outcomes will be unaware of the group assignments. The interventions (dry needling, kinesio taping, or combination) will be administered by separate therapists to prevent bias during outcome measurements. The statistical analysis will also be conducted without knowledge of group assignments to ensure objective analysis.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The study focuses on trigger points (TrPs) in the upper trapezius muscle, which are hyperirritable spots in skeletal muscle that are associated with localized pain and discomfort. These TrPs can lead to a variety of symptoms, including muscle stiffness, restricted range of motion, and referred pain in the neck and shoulder regions. The presence of active TrPs in the upper trapezius is commonly linked to musculoskeletal disorders, particularly in individuals with poor posture, repetitive movement, or prolonged muscle tension. This study investigates the effectiveness of dry needling (DN) and kinesio taping (KT) in addressing the clinical symptoms and neurocognitive parameters in patients with upper trapezius TrPs..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: dry needling: Deep dry needling (DDN) will be used to treat the participants throughout six sessions. The patients will be told to lie down with their heads in a neutral position. They will administer DDN treatments using 50 × 0.25 mm sterile stainless-steel needles (Tony dry needling, Korea).The 0.25 mm size reduces the likelihood of pain from a needle. A mark will first be sterilized on the skin before being pinched between the physical therapist's left index finger and thumb. To reach the trigger point, the needle will be inserted vertically into the skin (the correct position will be confirmed by a re-creation of a familiar referral pain or by a visible or palpable local twitch response (LTR). With 10 continuous repeats, the needle will move quickly forward and backward or until no more LTR will be visible. Intervention 2: Intervention group 2: Kinesio taping : Alcohol will first be used to clean the patient's skin. After handling and cutting the elastic band (Careous, Chinese tape) correctly (without touching the adhesive side), a space correction technique will be used to locate the TrP area in the upper trapezius muscle. When the upper trapezius muscle stretches to its maximum length by passively bending the head laterally to the other side, four 15-20 cm long I-shaped strips will form. The patient will be in a seated or prone position during the intervention. Each strip will be applied with a middle-third stretch of 25–50% . The elastic band's terminals won't be subject to any stretching. The tapes are adhered to one another diagonally. Intervention 3: Intervention group 3: Combination both of DN and KT: first we will start with the DDN procedure as we mentioned above and then immediately follow by the KT procedure also as we mentioned above.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Individual participant data will not be shared due to privacy concerns, ethical considerations, and institutional policies that restrict data sharing beyond the research team.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>karrar albomahmood</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Piche Shemiran, Engelab street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 903 385 3742</telephone>
        <email>masterkarar111@yahoo.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Azadeh shadmehr</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Rehabilitation, Piche Shemiran, Engelab street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1148965111</zip>
        <telephone>+98 21 7752 8468</telephone>
        <email>Shadmehr@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>patients aged 20–50 years.
patients with spontaneous pain or pain with movement in the neck and shoulder region related to active TrPs localized in the unilateral upper trapezius muscle
patients with symptom duration of at least three months
patients presenting a pain score equal to or higher than four in either rest or activity cervical spinal motion
willingness to participate in the study
Presence of 1 to 3 trigger points in one side.
Intact vision and auditory</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>history of whiplash injury
previous cervical surgery
cervical radiculopathy/myelopathy
fibromyalgia
having undergone any physical therapy intervention in the previous 6 month
fear of needles
any contraindication for DN, for example, anticoagulants or psychiatric disorders.
Cervicogenic headache</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M79.1 (Mus</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>M79.1 (Muscle Pain)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: dry needling: Deep dry needling (DDN) will be used to treat the participants throughout six sessions. The patients will be told to lie down with their heads in a neutral position. They will administer DDN treatments using 50 × 0.25 mm sterile stainless-steel needles (Tony dry needling, Korea).The 0.25 mm size reduces the likelihood of pain from a needle. A mark will first be sterilized on the skin before being pinched between the physical therapist's left index finger and thumb. To reach the trigger point, the needle will be inserted vertically into the skin (the correct position will be confirmed by a re-creation of a familiar referral pain or by a visible or palpable local twitch response (LTR). With 10 continuous repeats, the needle will move quickly forward and backward or until no more LTR will be visible</i_keyword>
      <i_keyword>Intervention group 2: Kinesio taping : Alcohol will first be used to clean the patient's skin. After handling and cutting the elastic band (Careous, Chinese tape) correctly (without touching the adhesive side), a space correction technique will be used to locate the TrP area in the upper trapezius muscle. When the upper trapezius muscle stretches to its maximum length by passively bending the head laterally to the other side, four 15-20 cm long I-shaped strips will form. The patient will be in a seated or prone position during the intervention. Each strip will be applied with a middle-third stretch of 25–50% . The elastic band's terminals won't be subject to any stretching. The tapes are adhered to one another diagonally</i_keyword>
      <i_keyword>Intervention group 3: Combination both of DN and KT: first we will start with the DDN procedure as we mentioned above and then immediately follow by the KT procedure also as we mentioned above.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The primary outcome variable for this study is pain intensity, which will be assessed using the Visual Analog Scale (VAS). This variable is chosen as the primary outcome because pain is a key clinical symptom of upper trapezius trigger points (TrPs) and is expected to change as a result of the interventions. The sample size calculation is based on the effect size related to changes in pain intensity following treatment with dry needling (DN) and kinesio taping (KT). Changes in pain intensity will help evaluate the effectiveness of the combined intervention on alleviating the discomfort caused by TrPs in the upper trapezius muscle. Timepoint: Before intervention (baseline)10 days after baseline (midpoint)3 weeks after baseline. Method of measurement: Visual analog scale (VAS) pain scale: The Visual Analog Scale (VAS) consists of a 100 mm continuous line with "no pain" at one end, representing a score of 0, and "worst possible pain" at the other end, representing a score of 100. The score is determined by measuring the distance (mm) between the two endpoints, and it is categorized as follows: no pain at 0-4 mm, mild pain at 5-44 mm, moderate pain at 45-74 mm, and severe pain at 75-100 mm.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain Pressure Threshold (PPT), measured by algometry: This will assess the pressure tolerance at the trigger point area, indicating changes in muscle sensitivity following the intervention. Timepoint: Before intervention (baseline)10 days after baseline (midpoint)3 weeks after baseline. Method of measurement: In terms of compression intensity, PPT refers to the point at which patients experience discomfort or pain rather than pressure. According to the International Association for the Study of Pain, PPT is the weakest intensity of stimulus that a subject feels as pain. A digital algometer (model SF-500, USA) will assess the PPT. The circling disk with a width of 1 cm will be placed opposite to the desired point, and pressure will increment gradually until the pain is felt and subjects indicate by saying “yes”. The normal value of three measurements will be detailed as PPT and the interval between repetitions was 30 s.</sec_outcome>
      <sec_outcome>Range of Motion (ROM), measured using photogrammetry: This will evaluate the flexibility and movement capacity of the neck. Timepoint: Before intervention (baseline)10 days after baseline (midpoint)3 weeks after baseline. Method of measurement: The position of the camera will be standardized throughout the test based on the subject’s position, and the tripod will be placed accordingly on the floor. The distance between the participant's feet and the tripod will be measured using a tape to ensure consistency and prevent any changes that could influence the measurements.The subject will wear two stretchy headbands to attach head markers. The markers will be placed directly over the external acoustic meatus (ear canal) and the top of the head. Cervical flexion and extension range of motion (ROM) will be assessed in the sagittal plane. The axis of the angle between two line segments will be marked by a marker over the external acoustic meatus. The first line segment will pass through the vertex and the marker’s axis. Following a chin tuck, a second vertical line marker will be placed over the external acoustic meatus.To ensure accurate marker placement, each marker will be marked with washable ink before being adhered. The examiner will be seated behind the camera to record the process. The subject will be instructed to flex the neck, hold the position for 5 seconds, return to the neutral position, and then extend the neck, hold for 5 seconds at the end of the range, and return to neutral. The examiner will assist by guiding the subject to perform cervical flexion with a chin tuck and extension with a raised chin. This process will be repeated three times.Cervical side bending ROM will be assessed in the frontal plane. Round markers with a 1.5 cm diameter will be glued onto key bony landmarks. The participant will be asked to position their head neutrally, aligning the head's center of mass with a vertical plane passing through the atlantooccipital joints, with the nose pointing forward in line with the sternum and navel. The sternal notch will serve as the reference point where two lines intersect: one line connecting the sternal notch marker to the forehead marker, and the other vertical, intersecting the sternal notch marker.Cervical side bending movements will be performed to both the right and left. Each marker's position will be marked with washable ink before being glued. The participant will be instructed to laterally flex to the right side and hold for 5 seconds at the maximum range. They will then return to the neutral position. The process will be repeated for the left side. This will be done three times, and the average range of motion will be calculated. Cervical AROM will be measured as the angular displacement from the neutral position to the right and left sides during side bending in the frontal plane.</sec_outcome>
      <sec_outcome>Neck Disability Index (NDI), a questionnaire assessing the level of disability due to neck pain. Timepoint: Before intervention (baseline)10 days after baseline (midpoint)3 weeks after baseline. Method of measurement: The NDI is scored from 0–50 points (0–100%) in which higher scores correspond to greater levels of disability. Using this system, a score of 5–14 points (10– 28%) is considered to constitute mild disability, 15–24 points (30–48%) is considered to constitute moderate disability, 25–38 points (50–68%) is considered to constitute a severe disability, and scores above 34 points (68%) indicate complete disability.</sec_outcome>
      <sec_outcome>Neck Proprioception, measured through a neck repositioning test to assess cervical joint position sense. Timepoint: Before intervention (baseline)10 days after baseline (midpoint)3 weeks after baseline. Method of measurement: Cervical proprioception:  Using the joint position error testing method of Revel et al., cervical joint repositioning errors will be quantified in degrees to evaluate cervical proprioception. The participants will face a target on the wall that will be 90 cm away while they will sit erect in a chair with back support. The patient will position their feet flat on the floor, their hips and knees bent to about 90 degrees, and their chest will strap to the chair to avoid thoracic rotation throughout the examination. The target, a circle with a diameter of 40 cm, will be set up so that the center of the circle will line up with the laser pointer on the subject's forehead. Participants will first need to spend a few seconds learning a neutral position as part of the protocol. Then, participants will be instructed to turn their head to the left or right, and then slowly rotate their head to line up with the center of the circular target (neutral position) while covering their eyes with a blindfold. (O') indicates the center of the circle. Centimeters will measure the distance between the center of the circle and the patient's indicated point (OC). OD indicates the distance between the patient's eyes and the target.  The measured centimeter distance between the circle's center and the light point will then be converted to degrees.      Using the formula (α=tan^(-1)⁡(OC/OD)),.</sec_outcome>
      <sec_outcome>Visual and Auditory Reaction Time and Anticipatory Skills, assessed using the Speed Anticipation Reaction Time (SART) system to evaluate neurocognitive aspects. Timepoint: Before intervention (baseline)10 days after baseline (midpoint)3 weeks after baseline. Method of measurement: Speed anticipation reaction time (SART): A color LCD will be connected to a laptop to display the SART test. The SART software program consists of six neurocognitive tests that measure high inter-tester and intra-tester reliability, visual choice reaction time, visual complex choice reaction time, auditory choice reaction time, and anticipatory skill of the ball at high and low speeds. Since none of the participants had any prior experience with the SART setup and will get familiar with the testing process used in the current study, the training parameter will be the same for everyone. Each participant will take a seat on a comfortable chair during the test. The chair can be raised or lowered to ensure that all participants' feet are on the ground. The LCD monitor will be 2 meters away from the participants' seats. Every participant used the identical two-handed grip to hold the joystick throughout the task at hand. They performed each test multiple times to get the participants comfortable with the system. When the participants are familiar with all of the tests, the main tests start.1.	Visual choice reaction time test: Four lamps will be illuminated on the monitor in the colors red, yellow, green, and blue to offer visual stimulation for this test. Participants must press the corresponding button on the joystick as quickly as they can when the examiner selects a button for each of the laptop's four colored bulbs.    2.	Visual complex choice reaction time test: The visual choice reaction time test has an incompatible mode that can be enabled by checking the reverse key at the program's beginning. This makes it possible to measure the complexity of the choice reaction time, and participants must press the joystick's reverse button after each stimulus.  3.	Auditory choice reaction time test: In this test, four separate frequencies—500 Hz, 1000 Hz, 3000 Hz, and 7000 Hz—will be used to stimulate the auditory system. The participants must press the related button on the joystick as soon as they hear the sound.  4.	Auditory complex choice reaction time test: Similar to the auditory choice reaction time test, the participants must press the joystick's reverse button after each stimulus in this test.      5.	The average reaction time and the number of tests where an error occurred are both shown in the reaction time test output report. The response time tests will be repeated five times for a total of ten times, with a 0.001 second measurement accuracy.     6.	Anticipatory skill with high and low speed: A soccer ball will move horizontally from the right end of the screen to the left end toward the gate at a continuous high or low speed (the examiner will choose the speed at random) on the anticipatory skill test page. The soccer ball will vanish when it reaches the black curtain on the left side of the screen. Participants must push the joystick button as quickly as they can while estimating the time the ball will arrive at the gate based on its speed.The results of the anticipatory tests include the average total prediction time, total user tolerance (TUT), the number of occasions when participants failed to respond for 10 seconds before an abnormal message was sent, and the average total prediction time without an abnormal response. Positive values in the declare values indicate a sooner reaction than the actual time, whereas negative values indicate a late response. Three sets of 10 repetitions each will make up the anticipatory skill exam. This chronometer will have a 0.001 ms accuracy.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-06-07</approval_date>
        <contact_name>Tehran university of medical sciences</contact_name>
        <contact_address>school of Rehabilitation, Piche Shemiran, Enghelab street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
